Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Advancements in creating skin grafts with biomaterials and stem cells are promising, but more research is needed for clinical application.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Cyclosporin effectively and safely treated skin diseases in three pets with no side effects.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Zinc supplementation may help improve treatment outcomes for chronic hepatitis C.

Stress hormones like cortisol may trigger psoriasis flare-ups.

A mother and daughter with similar hair loss conditions and identical HLA types suggest a genetic link between the conditions.

DKK-1 gene linked to hair loss in AGA and AA patients; more research needed for potential therapy.

An elderly man's hair grew back after treatment with secukinumab, possibly due to reduced scalp inflammation or the medication's direct effects.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Apremilast shows promise for several skin conditions but needs more research.

Imiquimod improved skin pigmentation in most patients with xeroderma pigmentosum and may prevent further skin cancer, but some treatments can have side effects.

Targeting IL-17 could help treat pattern hair loss.

Autoimmune diseases cause the immune system to attack the body, and management varies as some are curable and others are not.

Autoimmune diseases cause the immune system to attack the body, and management varies as some are curable and others are not.

Intralesional triamcinolone is the most effective treatment for alopecia areata, followed by excimer light therapy, and then topical minoxidil. The scalp responds better to treatment than the beard area.

Melatonin may help reduce the needed dose of prednisolone and improve hair growth in alopecia areata patients.

The document concludes that the understanding of scar formation is incomplete and current prevention and treatment for hypertrophic scars and keloids are not fully effective.

Mesenchymal stem cells show potential for skin healing and anti-aging, but more research is needed for safe use, especially regarding stem cells from induced pluripotent sources.

Costunolide may have multiple health benefits, including promoting hair growth and protecting against cancer and diabetes, but more research is needed.

Beta-sitosterol has potential health benefits but needs more research to fully understand its effects and improve its use in treatments.

Toll-like receptors are important for wound healing, but can slow it down in diabetic wounds.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.